TRPM2 and pancreatic neoplasm: The progression-free survival (PFS) period also significantly shortened as the TNM stage (Pearson’s coefficient = −0.89) and TRPM2 level (Pearson’s coefficient = −0.85) increased in pancreatic cancer patients (Fig. 2c).